Ruthie Davi and Elizabeth Lamont at Medidata AI discuss how adopting different approaches, such as synthetic control arms and remote monitoring, can aid researchers in investigating rare diseases.

Vikas Jain at Tata Consultancy Services examines three key avenues for AI to be adopted by the pharma industry and the benefits that each adoption can have.

Improving patient experience is increasingly recognised as essential to enhancing healthcare quality, satisfaction and health outcomes across the globe. By understanding the unique challenges and opportunities in different regions, healthcare systems can develop more effective, patient-centred care models.

Dr Mark Bunnage, Senior Vice President and Head of Global Research at Vertex Pharmaceuticals, talks to Pharmafocus about scientific innovation to help create transformative medicines for people living with serious diseases

Martin Cowie at AstraZeneca elaborates on the urgent need for faster diagnoses in the field of heart failure.

As the life sciences become increasingly aware of a lack in diversity, how can we improve this in genomics research?

How are corneal transplants advancing in the field of ophthalmology?

How is primary biliary cholangitis (PBC) currently affecting patients; and, more importantly, what hopes does PBC Awareness Month bring for new treatment options?

How can the combined power of multidisciplinary teams and precision medicine be harnessed for people living with bladder cancer?

Oral peptides are becoming an attractive drug candidate due to their efficacy and potency. How are parenteral drug products impacting the distribution of this new candidate?

Alex Fong and Olivia Houselander from Owen Mumford Pharmaceutical Services consider the action needed to make drug discovery processes more sustainable

Konrad Werhahn from UCB discusses how disease-modifying solutions may introduce a new era in treatment for epilepsies